Karimah S. Bell Lynum, PharmD

Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey

  • 3Articles
  • 10.8KReads
  • 2021–2026Active
  • 14Collaborators
  • 1Citations

About

Karimah S. Bell Lynum, PharmD is affiliated with Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey. Karimah S. Bell Lynum has authored or co-authored 3 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2021 and 2026. Their work focuses on Schizophrenia/Schizoaffective Disorders and Bipolar Disorder.

Publications

JCP
NNT, NNH, and LLH for Aripiprazole Once-Monthly in Schizophrenia
JCP
Safety and Efficacy of Maintenance Treatment with Aripiprazole Once-Monthly in Black/African American Adults With Bipolar I Disorder
JCP

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.